Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01094743 · ClinicalTrials.gov registry record · NA
Dispensing Evaluation of a Prototype Contact Lens and a Marketed Contact Lens
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 52
- Enrollment target
NCT01094743 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 52 participants.
The verdict
NCT01094743, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 52 participants
- Enrollment target
Study Summary
The purpose of this study is to compare visual acuity and redness of eyes between a prototype contact lens and an already marketed contact lens.
Interventions
- DEVICE galyfilcon A prototype lens
- DEVICE lotrafilcon B lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2010-02-01 |
| Est. Completion | 2010-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01094743
The ClinicalTrials.gov registry entry for NCT01094743 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which galyfilcon A prototype lens is the first listed.
NCT01094743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01094743 about?
NCT01094743 is a clinical study titled "Dispensing Evaluation of a Prototype Contact Lens and a Marketed Contact Lens". The purpose of this study is to compare visual acuity and redness of eyes between a prototype contact lens and an already marketed contact lens.
What is the current status of trial NCT01094743?
This trial is currently completed. It is a NA study. The enrollment target is 52 participants. The study started on 2010-02-01. Estimated completion is 2010-03-01.
What interventions are being tested in trial NCT01094743?
The interventions under investigation include: galyfilcon A prototype lens (DEVICE), lotrafilcon B lens (DEVICE).
Who is sponsoring clinical trial NCT01094743?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.